# Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation

Study · id `cardio:ct-nct07064616` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07064616](<https://clinicaltrials.gov/study/NCT07064616>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07064616

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07064616. Randomized; no masking; primary purpose treatment. Start 2025-06-25 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07064616, source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)
- Started: 2025-06-25 (actual) (ClinicalTrials.gov record NCT07064616, source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07064616, source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07064616, source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT07064616, source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07064616-2025-08-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation
- Acronym: PEACE
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): Catheter ablation using pulsed field ablation
- Intervention (Device): Catheter ablation using cryoballoon ablation
- Lead sponsor: Kitasato University
- Lead sponsor class: OTHER
- Collaborator: Nerima Hikarigaoka Hospital
- Collaborator class: UNKNOWN
- Collaborator: Sagamihara Kyodo Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 47c79893e2636eba47777c92c37efdfc9997e49903b13a130a8ffd37f5822305
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
